How tiny, durable proteins could transform the future of medicine
In short: Current life-saving proteins like insulin are often too large and fragile to be taken as pills. This video explores how molecular engineer Christopher Bahl uses computational design to create smaller, more resilient peptides.
Christopher Bahl, a molecular engineer, describes how peptides—a robust, smaller protein-based class of drugs—could transform medicine. Unlike larger proteins used in treatments such as insulin, which must be injected because they are too fragile for ingestion, these smaller molecules offer new possibilities for drug delivery.
By using computational design, Bahl aims to develop peptides capable of neutralizing the flu, protecting against botulism poisoning, and preventing the growth of cancer cells.
Opens the Intellect+ feed with this card first. Swipe up for the next one.
Sources
- Summary by Intellect · source: Christopher Bahl: A new type of medicine, custom-made with tiny proteins
To cite this card, link to https://intellectplus.co.uk/app/health-a-new-type-of-medicine-custom-made-with-tiny-proteins.
How we source, check and correct cards: Editorial standards.
General information, not professional advice. Spotted an error? Flag the card or see corrections and complaints.
Intellect Plus is a visual educational discovery platform for exploring fascinating facts and ideas. Brain Food, Not Brain Rot. What is Intellect Plus?
Related
More in Health · Latest · A–Z · All topics
